Adults:

Type II Diabetes / Cardiomyopathy & Heart Failure Treatment

NOW ENROLLING

A study for patients with Type II Diabetes at risk for a heart condition known as diabetic cardiomyopathy. This study is to evaluate the effects of an experimental drug, compared with placebo, that blocks an enzyme believed to be responsible for multiple complications of diabetes, including this form of heart failure.

Study ID: AT-001-2001

A study for patients with Type II Diabetes at risk for a heart condition known as diabetic cardiomyopathy. This study is to evaluate the effects of an experimental drug, compared with placebo, that blocks an enzyme believed to be responsible for multiple complications of diabetes, including this form of heart failure.

Download PDF

Covid Prevention

NOW ENROLLING

A study for subjects that live in the same household with someone who has tested positive for Covid-19. This study is to evaluate the effect and safety of an experimental drug, compared with placebo, to see if it can help prevent the spread of Covid-19.

Study ID: MK4482-013

A study for subjects that live in the same household with someone who has tested positive for Covid-19. This study is to evaluate the effect and safety of an experimental drug, compared with placebo, to see if it can help prevent the spread of Covid-19.

Download PDF

Chronic Kidney Disease Treatment

NOW ENROLLING

A study for patients with chronic kidney disease. This study is to evaluate a drug, compared with placebo, to help aid in the overall health of the kidneys.

Study ID: AZCK206

A study for patients with chronic kidney disease. This study is to evaluate a drug, compared with placebo, to help aid in the overall health of the kidneys.

Download PDF

Migraine Treatment

NOW ENROLLING

A study for patients with moderate to severe migraine headaches. This study is to evaluate a single dose of a nasal powder, compared with placebo, to relieve headache pain and provide relief from migraines.

Study ID: STS101-007

A study for patients with moderate to severe migraine headaches. This study is to evaluate a single dose of a nasal powder, compared with placebo, to relieve headache pain and provide relief from migraines.

Download PDF

Severe Hypertriglyceridemia treatment

NOW ENROLLING

A study for patients with high triglycerides levels. This study is to evaluate a drug, compared with placebo, to help reduce triglyceride levels in the blood. The study drug is an injectable medication given at week 0 and week 12.

Study ID: AROAPOC3-2001

A study for patients with high triglycerides levels. This study is to evaluate a drug, compared with placebo, to help reduce triglyceride levels in the blood. The study drug is an injectable medication given at week 0 and week 12.

Mixed Dyslipidemia treatment

NOW ENROLLING

A study for patients with high levels of cholesterol combined with elevated triglycerides. This study is to evaluate a drug, compared with placebo, to help reduce cholesterol and triglyceride levels in the blood. The study drug is an injectable medication given at week 0 and week 12.

Study ID: AROAPOC3-2002

A study for patients with high levels of cholesterol combined with elevated triglycerides. This study is to evaluate a drug, compared with placebo, to help reduce cholesterol and triglyceride levels in the blood. The study drug is an injectable medication given at week 0 and week 12.

Migraine Prevention

NOW ENROLLING

A study for patients with moderate to severe migraine headaches. This study is to compare the effects of two already FDA approved migraine medications for preventative treatment of episodic migraines in adults.

Study ID: I5Q-MC-CGBD

A study for patients with moderate to severe migraine headaches. This study is to compare the effects of two already FDA approved migraine medications for preventative treatment of episodic migraines in adults.

Download PDF

Hot Flash Treatment

NOW ENROLLING

A study for postmenopausal women, age 40-65, with moderate to severe hot flashes. This study is to evaluate the safety and effectiveness of an investigational oral, non-hormonal medication, compared with placebo, for hot flashes associated with menopause.

Study ID: OASIS 2

A study for postmenopausal women, age 40-65, with moderate to severe hot flashes. This study is to evaluate the safety and effectiveness of an investigational oral, non-hormonal medication, compared with placebo, for hot flashes associated with menopause.

Download PDF

Hypertension Treatment

NOW ENROLLING

A study for patients with mild to moderate hypertension. This study is to evaluate the safety and efficacy of an investigational injectable medication to treat hypertension.

Study ID: ALN-AGT01-002

A study for patients with mild to moderate hypertension. This study is to evaluate the safety and efficacy of an investigational injectable medication to treat hypertension.

Migraine Prevention

NOW ENROLLING

A study for patients with moderate to severe migraine headaches. This study is to evaluate the safety and efficacy of an already FDA approved migraine treatment medication, for preventative treatment of episodic migraines in adults.

Study ID: BHV3000-404

A study for patients with moderate to severe migraine headaches. This study is to evaluate the safety and efficacy of an already FDA approved migraine treatment medication, for preventative treatment of episodic migraines in adults.

Pediatric:

Migraine Treatment

NOW ENROLLING

A study for pediatric patients, ages 11-17 with migraine headaches. This study is to evaluate an oral disintegrating tablet in children and teens compared to placebo, to treat acute migraines. The study medication is FDA approved for the treatment and prevention of migraines in adult patients.

Study ID: BHV3000-311

A study for pediatric patients, ages 11-17 with migraine headaches. This study is to evaluate an oral disintegrating tablet in children and teens compared to placebo, to treat acute migraines. The study medication is FDA approved for the treatment and prevention of migraines in adult patients.

Download PDF

Migraine Treatment

NOW ENROLLING

A study for pediatric patients, ages 6 to less than 18, with migraine headaches. This study is to evaluate an oral tablet, compared to placebo, to treat acute migraines. The study medication is FDA approved for the treatment of adult migraine headaches.

Study ID: LAHV

A study for pediatric patients, ages 6 to less than 18, with migraine headaches. This study is to evaluate an oral tablet, compared to placebo, to treat acute migraines. The study medication is FDA approved for the treatment of adult migraine headaches.

Download PDF

Infant Formula

NOW ENROLLING

A formula study for infants 2 weeks to 2 months who are fussy on regular cow’s milk-based formula. This study is to evaluate the study formula to see if it improves fussiness.

Study ID: MJN3392

A formula study for infants 2 weeks to 2 months who are fussy on regular cow’s milk-based formula. This study is to evaluate the study formula to see if it improves fussiness.

Meningitis Vaccine

NOW ENROLLING

A study for a Meningitis vaccine in infants ages 6-7 months. This study is to evaluate the safety and immune response of an investigational vaccine that might protect against meningococcal disease.

Study ID: MET61

A study for a Meningitis vaccine in infants ages 6-7 months. This study is to evaluate the safety and immune response of an investigational vaccine that might protect against meningococcal disease.

Migraine Treatment

NOW ENROLLING

A study for pediatric patients, ages 6-17, with migraine headaches. This study is to evaluate an oral tablet, compared to placebo, to treat acute migraines. The study medication is FDA approved for the treatment of adult migraine headaches.

Study ID: Abbvie 3110-305

A study for pediatric patients, ages 6-17, with migraine headaches. This study is to evaluate an oral tablet, compared to placebo, to treat acute migraines. The study medication is FDA approved for the treatment of adult migraine headaches.

Nutritional Supplement

NOW ENROLLING

A study to evaluate the effects of oral nutritional supplementation with dietary counseling in children at risk of undernutrition.

Study ID: AL48

A study to evaluate the effects of oral nutritional supplementation with dietary counseling in children at risk of undernutrition.